262 related articles for article (PubMed ID: 26565911)
1. A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome.
Thompson Legault J; Strittmatter L; Tardif J; Sharma R; Tremblay-Vaillancourt V; Aubut C; Boucher G; Clish CB; Cyr D; Daneault C; Waters PJ; ; Vachon L; Morin C; Laprise C; Rioux JD; Mootha VK; Des Rosiers C
Cell Rep; 2015 Nov; 13(5):981-9. PubMed ID: 26565911
[TBL] [Abstract][Full Text] [Related]
2. Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.
Ruiz M; Cuillerier A; Daneault C; Deschênes S; Frayne IR; Bouchard B; Forest A; Legault JT; ; Vaz FM; Rioux JD; Burelle Y; Des Rosiers C
JCI Insight; 2019 Jul; 4(14):. PubMed ID: 31341105
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French canadian patients.
Burelle Y; Bemeur C; Rivard ME; Thompson Legault J; Boucher G; ; Morin C; Coderre L; Des Rosiers C
PLoS One; 2015; 10(3):e0120767. PubMed ID: 25835550
[TBL] [Abstract][Full Text] [Related]
4. Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.
Cuillerier A; Honarmand S; Cadete VJJ; Ruiz M; Forest A; Deschênes S; Beauchamp C; ; Charron G; Rioux JD; Des Rosiers C; Shoubridge EA; Burelle Y
Hum Mol Genet; 2017 Aug; 26(16):3186-3201. PubMed ID: 28575497
[TBL] [Abstract][Full Text] [Related]
5. LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency.
Debray FG; Morin C; Janvier A; Villeneuve J; Maranda B; Laframboise R; Lacroix J; Decarie JC; Robitaille Y; Lambert M; Robinson BH; Mitchell GA
J Med Genet; 2011 Mar; 48(3):183-9. PubMed ID: 21266382
[TBL] [Abstract][Full Text] [Related]
6. Expression signature of the Leigh syndrome French-Canadian type.
Bchetnia M; Tardif J; Morin C; Laprise C
Mol Genet Metab Rep; 2022 Mar; 30():100847. PubMed ID: 35242578
[TBL] [Abstract][Full Text] [Related]
7. Novel LRPPRC compound heterozygous mutation in a child with early-onset Leigh syndrome French-Canadian type: case report of an Italian patient.
Piro E; Serra G; Antona V; Giuffrè M; Giorgio E; Sirchia F; Schierz IAM; Brusco A; Corsello G
Ital J Pediatr; 2020 Sep; 46(1):140. PubMed ID: 32972427
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific responses to the LRPPRC founder mutation in French Canadian Leigh Syndrome.
Sasarman F; Nishimura T; Antonicka H; Weraarpachai W; Shoubridge EA;
Hum Mol Genet; 2015 Jan; 24(2):480-91. PubMed ID: 25214534
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 is required for expression of LRPPRC and cytochrome-
Mukaneza Y; Cohen A; Rivard MÈ; Tardif J; Deschênes S; Ruiz M; ; Laprise C; Des Rosiers C; Coderre L
Am J Physiol Cell Physiol; 2019 Jul; 317(1):C58-C67. PubMed ID: 30995105
[TBL] [Abstract][Full Text] [Related]
10. Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD
Iannetti EF; Smeitink JAM; Willems PHGM; Beyrath J; Koopman WJH
Cell Death Dis; 2018 Nov; 9(11):1135. PubMed ID: 30429455
[TBL] [Abstract][Full Text] [Related]
11. Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients.
Fois A; Boucher-Lafleur AM; Thompson Legault J; Renaud C; Morin C; Des Rosiers C; Coderre L; Laprise C; Lesage S;
PLoS One; 2020; 15(10):e0239860. PubMed ID: 33085679
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Signature of MELAS/Leigh Overlap Syndrome in Patient-specific Induced Pluripotent Stem Cells Model.
Hattori T; Hamazaki T; Kudo S; Shintaku H
Osaka City Med J; 2016 Dec; 62(2):69-76. PubMed ID: 30721581
[TBL] [Abstract][Full Text] [Related]
13. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.
Sharma R; Reinstadler B; Engelstad K; Skinner OS; Stackowitz E; Haller RG; Clish CB; Pierce K; Walker MA; Fryer R; Oglesbee D; Mao X; Shungu DC; Khatri A; Hirano M; De Vivo DC; Mootha VK
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463549
[TBL] [Abstract][Full Text] [Related]
14. LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population.
Oláhová M; Hardy SA; Hall J; Yarham JW; Haack TB; Wilson WC; Alston CL; He L; Aznauryan E; Brown RM; Brown GK; Morris AA; Mundy H; Broomfield A; Barbosa IA; Simpson MA; Deshpande C; Moeslinger D; Koch J; Stettner GM; Bonnen PE; Prokisch H; Lightowlers RN; McFarland R; Chrzanowska-Lightowlers ZM; Taylor RW
Brain; 2015 Dec; 138(Pt 12):3503-19. PubMed ID: 26510951
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome.
Yang YL; Sun F; Zhang Y; Qian N; Yuan Y; Wang ZX; Qi Y; Xiao JX; Wang XY; Qi ZY; Zhang YH; Jiang YW; Bao XH; Qin J; Wu XR
Chin Med J (Engl); 2006 Mar; 119(5):373-7. PubMed ID: 16542579
[TBL] [Abstract][Full Text] [Related]
16. Loss of LRPPRC causes ATP synthase deficiency.
Mourier A; Ruzzenente B; Brandt T; Kühlbrandt W; Larsson NG
Hum Mol Genet; 2014 May; 23(10):2580-92. PubMed ID: 24399447
[TBL] [Abstract][Full Text] [Related]
17. Targeting NAD
Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
[TBL] [Abstract][Full Text] [Related]
18. Infantile mitochondrial encephalopathy.
Uziel G; Ghezzi D; Zeviani M
Semin Fetal Neonatal Med; 2011 Aug; 16(4):205-15. PubMed ID: 21620787
[TBL] [Abstract][Full Text] [Related]
19. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.
Ortigoza-Escobar JD; Molero-Luis M; Arias A; Oyarzabal A; Darín N; Serrano M; Garcia-Cazorla A; Tondo M; Hernández M; Garcia-Villoria J; Casado M; Gort L; Mayr JA; Rodríguez-Pombo P; Ribes A; Artuch R; Pérez-Dueñas B
Brain; 2016 Jan; 139(Pt 1):31-8. PubMed ID: 26657515
[TBL] [Abstract][Full Text] [Related]
20. Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome.
Terburgh K; Coetzer J; Lindeque JZ; van der Westhuizen FH; Louw R
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166082. PubMed ID: 33486097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
